Search for: "Kevin Hulbert"
Results 21 - 40
of 112
Sorted by Relevance
|
Sort by Date
14 Jun 2013, 9:15 pm
Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff LLP. [read post]
6 Dec 2013, 12:30 pm
McDonnell Boehnen Hulbert & Berghoff LLP will be offering a live webinar on the "Top Patent Law Stories of 2013" on January 21, 2014 from 10:00 am to 11:15 am (CT). [read post]
16 Sep 2011, 9:22 pm
Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff LLP; Randi Isaacs, In-House Patent Counsel for Emory University's Office of Technology Transfer; and Brad Brockbank of Segue Consulting will focus on the specifics of the new law and the strategies needed to apply it successfully. [read post]
12 Dec 2014, 9:59 pm
McDonnell Boehnen Hulbert & Berghoff LLP will be offering a live webinar on the "Top Patent Law Stories of 2014" on January 20, 2014 from 10:00 am to 11:15 am (CT). [read post]
3 Dec 2016, 9:59 pm
McDonnell Boehnen Hulbert & Berghoff LLP will be offering a live webinar on the "Top Patent Law Stories of 2016" on January 18, 2017 from 10:00 am to 11:15 am (CT). [read post]
26 Jan 2019, 8:42 pm
Kagan of Banner & Witcoff, and Patent Docs author Kevin E. [read post]
5 Jul 2013, 8:44 pm
Kevin E. [read post]
27 Jul 2019, 9:16 pm
Borella and Kevin E. [read post]
14 Jun 2013, 9:22 pm
Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff; and Paul Golian, Assistant General Counsel at Bristol-Myers Squibb Company will consider such questions as: • How many and which existing gene patents will be challenged in post-grant proceedings at the USPTO? [read post]
28 Jun 2013, 9:59 pm
Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff LLP will help clarify and assess the effects of the Myriad decision for IP and research commercialization professionals, and provide guidance on how to adapt and preserve or even enhance the value of gene-based technologies. [read post]
8 Aug 2015, 9:00 pm
Kevin E. [read post]
14 Apr 2013, 8:43 pm
Patent Docs author Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff LLP will offer his insights on this critical case and debrief attendees on the oral argument to be held on April 15. [read post]
9 Sep 2017, 9:19 pm
Patent and Trademark Office, Jeffrey Hohenshell of Medtronic, Inc, and Patent Docs author Kevin Noonan of McDonnell Hulbert Berghoff & Boehnen LLP will analyze the opportunities and pitfalls for patent prosecutors raised by restriction requirements, discussing such topics as: • After a restriction requirement, how can a patent applicant make sure that the subsequent application falls into the section 121 "safe harbor," while... [read post]
17 Jun 2017, 9:11 pm
Patents Docs author Kevin E. [read post]
15 Feb 2013, 8:55 pm
Shubha Ghosh of the University of Wisconsin Law School, Patent Docs author Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff LLP, and Andrew Pincus of Mayer Brown LLP will discuss the February 19 oral argument in Bowman v. [read post]
30 Jul 2010, 9:40 pm
Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff LLP and Professor Chris Holman of the University of Missouri-Kansas City School of Law will take an in-depth look at the effect of the Myriad case on gene patenting and genetic diagnostics and address strategies that universities and innovators can employ to ensure sufficient patent protection and maximize investment opportunities. [read post]
30 Jan 2015, 9:59 pm
Paul Berghoff of McDonnell Boehnen Hulbert & Berghoff LLP, Andrei Iancu of Irell & Manella LLP, and Kevin Rhodes of 3M Innovative Properties Co. will untangle the predictions and give their own best analysis regarding the impact of the Supreme Court's decision in Teva v. [read post]
21 Jan 2023, 8:46 pm
McDonnell Boehnen Hulbert & Berghoff LLP will be offering a live webinar on the "Top Patent Law Stories of 2022" on January 24, 2023 from 10:00 am to 11:15 am (CT). [read post]
30 Mar 2012, 6:15 pm
Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff; Jonathan Singer of Fish & Richardson, who has represented the Mayo Clinic in its patent litigation with Prometheus; and Bryan Zielinski, Vice President, Assistant General Counsel, and Head of Pfizer's Business Unit IP group, will examine ways forward after the Mayo decision. [read post]
14 Feb 2014, 8:47 pm
Kevin... [read post]
